3 years 0
Extreme 0.0008
0.01
5 years 0
Extreme 0.0008
0.05
Manager TitleAgeSince
Chief Executive Officer 84 2020-05-31
Chief Operating Officer 72 2020-05-31
Chief Tech/Sci/R&D Officer 72 2021-05-03
Director TitleAgeSince
Chairman 84 2020-05-31
Director/Board Member 72 2020-05-31
Director/Board Member 56 -
Change 5-day change 1-year change 3-year change Capi.($)
-11.11%+14.29%-69.23%-91.58% 0
+1.36%+1.40%+30.24%+201.92% 367B
+1.74%+9.96%+35.64%+144.31% 287B
+4.16%+3.66%+44.86%+827.35% 155B
+2.46%+14.51%+38.33%+28.28% 134B
+1.30%+4.93%+23.16%+77.41% 104B
+1.64%+3.96%-4.83%+18.60% 77.03B
+0.31%+4.84%+6.74%+115.13% 74.48B
+4.19%-3.57% - - 64.68B
+0.18%+6.45%+11.49%+48.95% 55.93B
Average +0.62%+4.13%+12.93%+152.26% 132.02B
Weighted average by Cap. +1.93%+5.00%+29.18%+213.98%
Logo HALBERD
Halberd Corporation is a technology holding company. The Company is focused on developing solutions for healthcare and medical applications. Its portfolio includes approaches to disease treatment, diagnostic technologies, and artificial intelligence (AI)-powered healthcare platforms. It has acquired licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and cerebrospinal fluid-related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other viruses. Its subsidiary, NeuroSense AI Corp., is a behavioral intelligence platform in development combining AI with multi-modal sensor technology that integrates ultrasonic vocalization analysis, micro-movement tracking, and social behavior monitoring through Claude AI-powered interpretation to provide unprecedented insights into brain health and recovery patterns. Its subsidiaries also include Alaric Corporation and Extendalife, Inc.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. HALB Stock